How To Trade (APGE) - news.stocktradersdaily.com
3 days ago • Google News
Apogee Therapeutics, Inc. Common Stock (APGE)
US$ 39.89-2.33%
Price Chart
Key Statistics
Market Cap
$ 2.33B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.27M
52W High
$ 63.50
52W Low
$ 26.20
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
37.1372
200-Day MA
44.3521
52 Week High
63.5
52 Week Low
26.2
About APGE
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pul.
Employees
196
Headquarters
Waltham, MA
CEO
Dr. Michael Thomas Henderson M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg